Satoshi Yoshihara

Associate Professor

Hyogo medical university

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Satoshi Yoshihara is an Associate Professor at Hyogo Medical University, Japan. His research primarily focuses on hematopoietic stem cell transplantation, particularly in the context of acute myeloid leukemia and malignant lymphoma. His recent publications explore the prognostic factors affecting transplantation outcomes and the impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Satoshi Yoshihara

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Fludarabine Plus Myeloablative Dose of Busulfan Regimen Was Associated with High Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Lymphoma: A Propensity Score-Matched Comparison Study with Fludarabine Plus High-Dose Melphalan

Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy

The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted time series analysis

Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remission

Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis

Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission

Risk factors for CAR‐T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan

A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy

Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain

T‐cell lymphoma, B‐cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone

Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation

Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis

Severe acute heart failure during or following cytokine release syndrome after CAR T-cell therapy

Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia

Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study

Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma

Collaborators (10)

Masahiro Teramoto

Naoki Hosen

Takaaki Konuma

Ryo Hanajiri

Tetsuhisa Kitamura

Masamitsu Yanada

Satoshi Takahashi

Yutaka Shimazu

Akihito Shinohara

Nobuhiko Nakamura

Make your next move.